Gianfranco Nazzi, EVP, International Markets at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 548 shares at $11.77 ($6K) on 2020-03-03, disclosed to the SEC on 2020-03-05.
Scheduled sale ($6k) by EVP, International Markets under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TEVA | SELL | 2021-03-02 | $1.6M | — | Filing → |
| TEVA | SELL | 2021-02-11 | $550K | — | Filing → |
| TEVA | SELL | 2020-03-19 | $2K | — | Filing → |